Skip to main content
Log in

Polymorphic markers Ala455Val of the THBD gene and Arg353Gln of the F7 gene and genetic association with unfavorable outcomes of coronary atherosclerosis in patients with a history of acute ischemic heart disease

  • Human Genetics
  • Published:
Russian Journal of Genetics Aims and scope Submit manuscript

Abstract

The polymorphic markers Ala455Val of the THBD gene and Arg353Gln of the F7 gene were tested for association with the frequency of unfavorable outcomes in patients with a history of acute ischemic heart disease. The study involved 1145 patients hospitalized in cardiology clinics of Moscow, St. Petersburg, Kazan, Chelyabinsk, Perm, Stavropol, and Rostov-on-Don because of acute ischemic heart disease. The patients were followed up for up to 62.5 months. None of the markers displayed a significant association with the time to an endpoint. The patients were then grouped by sex. In females, the frequency of unfavorable outcomes (fatal or nonfatal myocardial infarction and fatal or nonfatal stroke) was higher in carriers of allele Val of the Ala344Val polymorphic marker of the THBD gene and carriers of genotype Arg/Arg of the Arg353Gln polymorphic marker of the F7 gene, but the difference was not statistically significant. Such an increase in frequency was not observed in males. To study the combined effect of the polymorphic markers of the THBD and F7 genes, the course of ischemic heart disease was compared for two female subgroups. One included carriers of allele Val of the Ala344Val polymorphic marker of the THBD gene and genotype Arg/Arg of the Arg353Gln polymorphic marker of the F7 gene; the other subgroup included carriers of genotype Ala/Ala of the Ala455Val polymorphic marker of the THBD gene and allele Gln of the Arg353Gln polymorphic marker of the F7 gene. The frequency of unfavorable outcomes in the first subgroup was higher than in the second one. The time to an endpoin was 40.5 months (95% confidence interval (CI) 33.5–47.6) in the first subgroup and 51.6 months (95% CI 45.0–58.1) in the second subgroup (χ2 = 4.15, P = 0.042). The results made it possible to assume that the F7 and THBD genes play an important role in genetic predisposition to unfavorable outcomes in patients with a history of acute ischemic heart disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Nazarenko, G.I., Kleimenova, E.B., and Gushchina, N.N., Study of Genetic Markers and Traditional Risk Factors in Development of Ischemic Heart Disease, Ross. Med. Vesti, 2009, vol. 14, no. 1, pp. 47–54.

    Google Scholar 

  2. Oganov, R.G., Pogosova, G.V., Koltunov, I.E., et al., RELIF—Regular Treatment and Prophylactics—the Key to Improving Situation with Cardiovascular Diseases in Russia: Results of Russian Multicenter Study: Ch. III, Kardiol., 2008, vol. 48, no. 4, pp. 46–53.

    CAS  Google Scholar 

  3. Arutyunov, G.P., Coronary Atherothrombozis: New Data for a Novel Insight into Eternal Problems, Serdtse, 2004, no. 4, pp. 12–15.

  4. Sidorenko, B.A., Zateishchikov, D.A., and Zotova, I.V., Predictors of Intracardial Thrombosis in Patients with Ciliary Arrhythmia: Factors of Hemostasis, Markers of Inflammation, and Genetic Factors, Kardiol., 2008, no. 2, pp. 36–40.

  5. Kogan-Ponomarev, M.Ya., Dobrovol’skii, A.V., Staroverov, I.I., et al., Coagulogical Specificity in Patients with Myocardial Infarction upon Early Spontaneous and Medicinal Rehabilitation of Coronary Bloodstream, Kardiol., 1994, no. 34, pp. 4–10.

  6. Panchenko, E.P. and Dobrovol’skii, A.B., Trombozy v kardiologii. Mekhanizmy razvitiya i vozmozhnosti terapii (Thromboses in Cardiology: Mechanisms of Development and the Capability of Therapy), Moscow: Sport i kul’tura, 1999.

    Google Scholar 

  7. Damani, M.D. and Topol, M.D., Future Use of Genomics in Coronary Artery Disease, J. Am. Coll. Cardiol., 2007, vol. 50, no. 20, pp. 1933–1940.

    Article  PubMed  CAS  Google Scholar 

  8. Ye, Z., Liu, E.H., Higgins, J.P., et al., Seven Hemostatic Gene Polymorphisms in Coronary Disease: Meta-Analysis of 66.155 Cases and 91.307 Controls, Lancet, 2006, vol. 367, pp. 651–658.

    Article  PubMed  CAS  Google Scholar 

  9. Agapkina, Yu.V., Nikitin, A.G., Brovkin, A.N., et al., Polymorphic Markers G(-455)A of the FGV Gene and C(-1654)T of the RROS Gene and the Genetic Susceptibility to Unfavorable Clinical Course of Ischemic Heart Disease among Patients, That Sustained Acute Coronary Syndrome, Mol. Biol., 2010, vol. 44, no. 4, pp. 613–619.

    Article  Google Scholar 

  10. Wu, A.H. and Tsongalis, G.J., Correlation of Polymorphisms to Coagulation and Biochemical Risk Factors for Cardiovascular Diseases, Am. J. Cardiol., 2001, vol. 87, no. 12, pp. 1361–1366.

    Article  PubMed  CAS  Google Scholar 

  11. Girelli, D., Russo, C., Ferraresi, P., et al., Polymorphisms in the Factor VII Gene and the Risk of Myocardial Infarction in Patients with Coronary Artery Disease, N. Engl. J. Med., 2000, vol. 343, no. 11, pp. 774–780.

    Article  PubMed  CAS  Google Scholar 

  12. Sadler, J.E., Thrombomodulin Structure and Function, Thromb. Haemost., 1997, vol. 78, no. 1, pp. 392–395.

    PubMed  CAS  Google Scholar 

  13. Iacoviello, L., Di Castelnuovo, A., de Knijff, P., et al., Polymorphisms in the Coagulation Factor VII Gene and the Risk of Myocardial Infarction, N. Engl. J. Med., 1998, vol. 338, pp. 79–85.

    Article  PubMed  CAS  Google Scholar 

  14. Lane, A., Green, F., Scarabin, P.Y., et al., Factor VII Arg/Gln353 Polymorphism Determines Factor VII Coagulant Activity in Patients with Myocardial Infarction (MI) and Control Subjects in Belfast and in France but Is not a Strong Indicator of MI Risk in the ECTIM Study, Atherosclerosis, 1996, vol. 119, pp. 119–127.

    Article  PubMed  CAS  Google Scholar 

  15. Doggen, C.J.M., Manger Cats, V., Bertina, R.M., et al., A Genetic Propensity to High Factor VII Is not Associated with the Risk of Myocardial Infarction in Men, Thromb. Haemost., 1998, vol. 80, pp. 281–285.

    PubMed  CAS  Google Scholar 

  16. Wang, X.L., Wang, J., McCredie, R.M., et al., Polymorphisms of Factor V, Factor VII, and Fibrinogen Genes: Relevance to Severity of Coronary Artery Disease, Arterioscler. Thromb. Vasc. Biol., 1997, vol. 17, pp. 246–251.

    Article  PubMed  CAS  Google Scholar 

  17. Wu, K.K., Aleksic, N., Ahn, C., et al., Atherosclerosis Risk in Communities Study (ARIC) Investigators: Thrombomodulin Ala455Val Polymorphism and Risk of Coronary Heart Disease, Circulation, 2001, vol. 103, pp. 1386–1389.

    Article  PubMed  CAS  Google Scholar 

  18. Ohlin, A.K., Holm, J., and Hillarp, A., Genetic Variation in the Human Thrombomodulin Promoter Locus and Prognosis after Acute Coronary Syndrome, Thromb. Res., 2004, vol. 113, no. 5, pp. 319–326.

    Article  PubMed  Google Scholar 

  19. Sidorenko, B.A., Zateishchikov, D.A., and Dankovtseva, E.N., Polymorphism of Hemostasis Factor Genes in Patients with Early Onset Ischemic Heart Disease, Kardiol., 2006, no. 2, pp. 56–65.

  20. Mathew, C.G.P., The Isolation of High Molecular Weight Eukaryotic DNA, Nucleic Acids, 1984, vol. 2, pp. 31–34.

    Article  CAS  Google Scholar 

  21. R Development Core Team. R: A Language and Environment for Statistical Computing, Vienna, Austria, 2010.

  22. Konstantoulas, C.J., Cooper, J., Warnock, G., et al., A Combination of Two Common Thrombomodulin Gene Variants (-1208-1209TTdelTT and A455V) Influence Risk of Coronary Heart Disease: A Prospective Study in Men, Atherosclerosis, 2004, vol. 177, no. 1, pp. 97–104.

    Article  PubMed  CAS  Google Scholar 

  23. Nakabayashi, M., Yamamoto, S., and Suzuki, K., Analysis of Thrombomodulin Gene Polymorphism in Women with Severe Early-Onset Preeclampsia, Semin. Thromb. Haemost., 1999, vol. 25, no. 5, pp. 473–479.

    Article  CAS  Google Scholar 

  24. Aleksic, N., Folsom, A.R., Cushman, M., et al., Prospective Study of the A455V Polymorphism in the Thrombomodulin Gene, Plasma Thrombomodulin, and Incidence Venous Thromboembolism: The LITE Study, J. Thromb. Haemost., 2003, vol. 1, no. 1, pp. 88–94.

    Article  PubMed  CAS  Google Scholar 

  25. Yang, L., Manithody, C., Walston, T.D., et al., Thrombomodulin Enhances the Reactivity of Thrombin with Protein C Inhibitor by Providing Both a Binding-Site for the Serpin and Allosterically Modulating the Activity of Thrombin, J. Biol. Chem., 2003, vol. 278, no. 39, pp. 37465–37470.

    Article  PubMed  CAS  Google Scholar 

  26. Auro, K., Alanne, M., Kristiansson, K., et al., Combined Effects of Thrombosis Pathway Gene Variants Predict Cardiovascular Events, PLoS Genet., 2007, vol. 3, no. 7.

  27. Bernardi, F., Arcieri, P., Bertina, R.M., et al., Contribution of Factor VII Genotype to Activated FVII Levels: Differences in Genotype Frequencies between Northern and Southern European Populations, Arterioscler. Thromb. Vasc. Biol., 1997, vol. 17, no. 11, pp. 2548–2553.

    Article  PubMed  CAS  Google Scholar 

  28. Ghaddar, H.M., Folsom, A.R., Aleksic, N., et al., Correlation of Factor VIIa Values with Factor VII Gene Polymorphism, Fasting and Postprandial Triglyceride Levels, and Subclinical Carotid Atherosclerosis, Circulation, 1998, vol. 98, no. 25, pp. 2815–2821.

    PubMed  CAS  Google Scholar 

  29. Kathiresan, S., Yang, Q., Larson, M.G., et al., Common Genetic Variation in Five Thrombosis Genes and Relations to Plasma Hemostatic Protein Level and Cardiovascular Disease Risk, Arterioscler. Thromb. Vasc. Biol., 2006, vol. 26, pp. 1405–1412.

    Article  PubMed  CAS  Google Scholar 

  30. Blagodatskikh, K.A., Evdokimova, M.A., Agapkina, Yu.V., et al., Polymorphic Markers G(-174)C of the IL6 Gene and G(-1082)A of the IL10 Gene and the Genetic Susceptibility to Unfavorable Clinical Course of Ischemic Heart Disease among Patients, That Sustained Acute Coronary Syndrome, Mol. Biol. (Moscow), 2010, vol. 37, no. 5, pp. 1–8.

    Google Scholar 

  31. Blagodatskikh, K.A., Nikitin, A.G., Pushkov, A.A., et al., Polymorphic Markers G2667S, G3014A, S3872T, A5237G of the @SRR@ Gene and the Genetic Susceptibility to Unfavorable Clinical Course of Ischemic Heart Disease among Patients, That Sustained Acute Coronary Disease and among Patients, That Sustained Exacerbation of Ischemic Heart Disease, Med. Genet., 2011, no. 4, pp. 3–9.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. A. Pushkov.

Additional information

Original Russian Text © A.A. Pushkov, K.A. Blagodatskikh, A.G. Nikitin, et al., 2011, published in Genetika, 2011, Vol. 47, No.10, pp. 1386–1392.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pushkov, A.A., Blagodatskikh, K.A., Nikitin, A.G. et al. Polymorphic markers Ala455Val of the THBD gene and Arg353Gln of the F7 gene and genetic association with unfavorable outcomes of coronary atherosclerosis in patients with a history of acute ischemic heart disease. Russ J Genet 47, 1234–1239 (2011). https://doi.org/10.1134/S1022795411100140

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1022795411100140

Keywords

Navigation